论著

天麻止痫汤分别联合托吡酯和卡马西平治疗对癫痫患者记忆能力及甘丙肽、铁调节转运体1的影响

Effects of Tianma Zhixian Decoction combined with topiramate and carbamazepine on memory ability,galanin and iron regulatory transporter 1 in patients with epilepsy

:63-69
 
目的 探讨天麻止痫汤分别联合托吡酯和卡马西平治疗对癫痫患者记忆能力及甘丙肽、铁调节转运体1(IREG1)的影响。方法 选择我院2019年6月—2022年6月收治的85例癫痫患者,其中21例予天麻止痫汤联合托吡酯治疗(A组),23例予天麻止痫汤联合卡马西平治疗(B组),22例予托吡酯治疗(C组),19例予卡马西平治疗(D组)。评价4组的治疗效果、记忆能力、甘丙肽和IREG1水平等指标,并进行统计比较。结果 4组治疗总有效率和完全控制率比较差异均无统计学意义(P>0.05)。两两比较,A组总有效率高于C组和D组(P<0.05),B组总有效率高于C组和D组(P<0.05),A组和B组总有效率比较差异无统计学意义(P>0.05);A组患者治疗后中医症候积分、癫痫发作次数及发作持续时间均少于其他3组(P<0.05);A组患者治疗后视觉再认、图片回忆、视觉再生、联想学习、理解、顺背和倒背数字和记忆商数(MQ)均较治疗前升高,且高于其他3组(P<0.05);4组治疗后甘丙肽水平升高(P<0.05),IREG1蛋白表达量降低(P<0.05),A组治疗后甘丙肽水平高于其他3组,IREG1蛋白表达量低于其他3组(P<0.05);4组不良反应发生率比较差异无统计学意义(P>0.05)。结论 天麻止痫汤联合托吡酯或卡马西平治疗癫痫的总有效率、安全性均较好,且对患者记忆能力影响较小;而天麻止痫汤在改善癫痫症状、减少癫痫发作次数及发作持续时间、抑制甘丙肽和IREG1异常表达方面更具优势。
Objective To investigate the effects of Tianma Zhixian Decoction combined with topiramate and carbamazepine on memory ability and galanin and iron exporter ferroportin 1(IREG1)in patients with epilepsy.Methods A total of 85 patients with epilepsy were admitted to our hospital from June 2019 to June 2022,including 21 patients treated with Tianma Zhixian Decoction combined with topiramate(Group A),23 patients treated with Tianma Zhixian Decoction combined with carbamazepine(Group B),22 patients treated with topiramate(Group C),and 19 patients treated with carbamazepine(Group D).The therapeutic effect,memory ability,galanin and IREG1 levels were compared among the four groups.Results There were no significant differences in the total treatment response rate and complete control rate between the four groups(P>0.05).By pairwise comparison,the total response rate in Group A was significantly higher than those in Group C and Group D(P<0.05),the rate in Group B was significantly higher than those in Group C and Group D(P<0.05),there was no significant difference in the total response rate between group A and B(P>0.05).In group A,the TCM syndrome score,seizure attacks and duration of seizure were significantly less than those of the other three groups(P<0.05).In Group A,visual re-recognition,picture recall,visual regeneration,associative learning,understanding,numbers recitation forward or backward and MQ values were all significantly improved compared with those before treatment,which was significantly higher than that in the other three groups(P<0.05).Galanin levels significantly increased in the four groups(P<0.05)after treatment,while IREG 1 protein expression decreased(P<0.05).Galanin level in group A was significantly higher than the other three groups,IREG 1 protein expression was significantly lower than that in the other three groups(P<0.05).There was no significant difference in the incidence of adverse reactions among the four groups(P>0.05).Conclusions Tianma Zhixian Decoction combined with topiramate or carbamazepine is effective and safe in the treatment of epilepsy,with little effect on the memory ability of patients.Tianma Zhixian Decoction has more advantages in improving the complete control rate of epilepsy,improving epilepsy symptoms,reducing the number and duration of seizures,and inhibiting the abnormal expression of galanin and IREG1.
论著

LACE风险模型下的护理干预策略对心脏瓣膜置换术后患者院外自我管理能力及再入院率的影响

Effect of nursing intervention strategies under LACE risk model on self-management ability outside hospital and readmission rate of patients after heart valve replacement

:58-62
 
目的 观察LACE风险模型下的护理干预策略在心脏瓣膜置换术后患者中的应用效果。方法 选取我院2021年3月—2022年3月心脏瓣膜置换术后患者82例作为研究对象,以患者入院顺序编号分为对照组、观察组,各41例。对照组予以常规护理,观察组予以LACE风险模型下的护理干预。比较2组出院时、干预后的自我管理能力及负性情绪;干预期间的术后并发症发生率、再入院率、用药依从性。结果 干预后观察组自我管理环境、自我管理行为、自我管理认知评分高于对照组(P<0.05);观察组术后并发症发生率7.32%(3/41)、再入院率4.88%(2/41)均低于对照组24.39%(10/41)、21.95%(9/41,P<0.05);观察组用药依从率97.56%(40/41)高于对照组78.05%(32/41,P<0.05);干预后观察组汉密尔顿抑郁量表评分、汉密尔顿焦虑量表评分低于对照组(P<0.05)。结论 心脏瓣膜置换术后患者进行LACE风险模型下的护理干预后,患者的自我管理能力及用药依从性明显改善,同时其并发症发生率和再入院率有效降低,焦虑、抑郁等负性情绪得到缓解,具有良好护理效果。
Objective To observe the effect of nursing intervention strategy under LACE risk model in patients after heart valve replacement.Methods From March 2021 to March 2022,82 patients with heart valve replacement were enrolled as the study objects.The patients were divided into control group and observation group according to the order of admission,with 41 patients in each group.The control group was given routine nursing,and the observation group was given nursing intervention under LACE risk model.The self-management ability and negative emotions at discharge and after intervention were compared between the two groups.The incidence of postoperative complications,readmission rate and medication compliance during the intervention period were also compared.Results After intervention,the scores of self-management environment,self-management behavior and self-management cognition in the observation group were higher than those in the control group(P<0.05).The postoperative complication rate of 7.32%(3/41)and readmission rate of 4.88%(2/41)in the observation group were lower than those of 24.39%(10/41)and 21.95%(9/41)in the control group(P<0.05).The compliance rate of the observation group(97.56%)was higher than that of the control group(78.05%,P<0.05).After intervention,the scores of Hamilton Depression Scale and Hamilton Anxiety Scale in the observation group were lower than those in the control group(P<0.05).Conclusions After nursing intervention under LACE risk model for patients after heart valve replacement,the self-management ability and medication compliance of patients have been significantly improved,the incidence of complications and readmission rate have been effectively reduced,and negative emotions such as anxiety and depression have been alleviated,which has good nursing effect.
论著

新斯的明拮抗顺阿曲库铵的时机对患者腹腔镜结直肠癌根治术后肌松残留和早期肺功能的影响

Effect of neostigmine antagonizing timing of cisatracurium on residual muscle relaxation and early lung function after laparoscopic radical resection of colorectal cancer

:70-74
 
目的 探究新斯的明拮抗顺阿曲库铵的时机对患者腹腔镜结直肠癌根治术后肌松残留和早期肺功能的影响。方法 选取于2021年2月—2022年9月在我院行结肠癌根治手术的194例患者为研究对象,以随机数字表法将患者分为空白对照组和试验组,然后结合给予新斯的明治疗时所体现的4个成串刺激(TOF)比值将试验组患者分为试验组A(TOF≤0.1)、试验组B(0.10.8)。对比组间肌松残余情况以及肺功能情况。结果 插管前,试验组A患者TOF比值低于其他组(P<0.01),空白对照组患者TOF比值高于其他组(P<0.01);空白对照组分别与试验组A~E在复苏室接受观察的时间比较,差异无统计学意义(P>0.01);试验组A患者肌松恢复指数低于其他组(P<0.01),空白对照组患者肌松恢复指数高于其他组(P<0.01)。插管前、拔管0.5 h以及拔管24 h时,组间1秒用力呼气容积(FEV1)、用力肺活量(FVC)和FEV1/FVC比较差异无统计学意义(P>0.05)。结论 结直肠癌根治术后给予新斯的明,有助于加快肌松恢复,但不会影响复苏室停留时间与肺功能水平。
Objective To investigate the effect of timing of neostigmine antagonizing cisatracurium on residual muscle relaxation and early lung function in patients underwent laparoscopic radical resection of colorectal cancer.Methods February 2021 to September 2022,194 patients who underwent radical colon cancer surgery in our hospital were selected as the research subjects.The patients were randomly divided into a blank control group and an experimental group using a random number table method.Then,combined with the train-of-four(TOF)ratios observed during neostigmine treatment,the experimental group patients were divided into experimental group A(TOF≤0.1),experimental group B(0.10.8).The residual muscle relaxation and lung function between groups were compared.Results Before intubation,the TOF ratio of patients in experimental group A was lower than that of other groups(P<0.01),while the TOF ratio of patients in the blank control group was higher than that of other groups(P<0.01).There was no significant difference in the observation time between the blank control group and the experimental group A~E in the postanesthesia care unit(P>0.01).The muscle relaxation recovery index of patients in experimental group A was lower than that of other groups(P<0.01),while the muscle relaxation recovery index of patients in the blank control group was higher than that of other groups(P<0.01).There were no significant differences in force expiratory volume in one second(FEV1),forced Vital capacity(FVC)and FEV1/FVC between groups before intubation,0.5 h after extubation and 24 h after extubation(P>0.05).Conclusions Administration of neostigmine after radical surgery for colorectal cancer can accelerate muscle relaxation recovery,but it will not affect the residence time of the postanesthesia care unit and lung function levels.
综述

白内障超声乳化术对糖尿病患者眼表影响的研究进展

Research progress on the effects of phacoemulsification on the ocular surface in patients with diabetes mellitus

:112-119
 
糖尿病已成为全球最严重的健康问题之一。需要白内障手术的糖尿病患者也日益增多,虽然糖尿病的眼表并发症很常见,但由于糖尿病患者全身和眼部疾病十分复杂,使得眼前段如角结膜和泪腺的糖尿病并发症往往被忽视。糖尿病患者白内障超声乳化术有引发或加重眼前节疾病的风险,包括干眼病(DED)、角膜上皮糜烂、上皮缺损迁延不愈,甚至威胁视力的角膜溃疡。这些风险里最为常见的是DED,并且可能因白内障超声乳化手术而加重。眼科医生需要在手术前预先评估已存在的DED是否需要术前治疗,并且需要注意在已存在 DED 的情况下,各项术前检查数据测量的准确性会降低,以及尽可能减少对眼表造成损害的各种手术因素;并考虑通过管理减少术后 DED。本综述就评估白内障超声乳化术对合并糖尿病的老年性白内障患者的眼表术中的影响因素进行分析。
Diabetes mellitus(DM)has become one of the most serious health problems in the world. The number of diabetic patients requiring cataract surgery is also increasing. Although ocular surface complications of DM are common,the complexity of systemic and ocular disease in diabetic patients makes diabetic complications in the anterior segment,such as the cornea and lacrimal gland,often be overlooked. Phacoemulsification in diabetic patients carries the risk of triggering or exacerbating ocular segment disease,including dry eye disease,corneal epithelial erosion,persistent epithelial defects and even vision-threatening corneal ulcers. The most common of these risks is dry eye disease,and it can be exacerbated by cataract phacoemulsification. Ophthalmologists need to preemptively assess the need for preoperative treatment of pre-existing dry eye disease(DED),be aware of the reduced accuracy of preoperative data measurements in the presence of DED,and minimize surgical factors that can damage the ocular surface;and consider management to reduce postoperative DED. In this review,we analyze the factors that influence phacoemulsification in ocular surface surgery for senile cataract patients with diabetes.
论著

互联网+联合分段式心理干预对结肠癌患者生活质量及希望水平的影响

Effect of internet combined with segmented psychological intervention on quality of life and hope level of colon cancer patients

:73-77
 
目的 分析互联网+联合分段式心理干预对结肠癌患者生活质量及希望水平的影响。方法 采用随机数字表法对照试验,于2019年12月—2022年12月选取本院收治的100例结肠癌患者,分为参照组(50例,给予常规心理护理)与试验组(50例,给予互联网+联合分段式心理护理),比较2组患者在护理前后的精神状态、生活质量、希望水平及护理满意度。结果 护理后,2组患者的简明精神病评定量表(BPRS)评分均降低,且试验组评分优于参照组(P<0.05);2组患者的简明健康状况调查表(SF-36)各维度评分均升高,并且试验组评分更高(P<0.05);2组患者的Herth希望量表(HHI)各维度评分均升高,且试验组评分高于参照组(P<0.05);试验组患者(96.00%)护理满意度高于参照组(80.00%)(P<0.05)。结论 结肠癌患者采用互联网+联合分段式心理干预可改善患者精神状态,提高结肠癌患者生活质量、希望水平。
Objective To analyze the effect of internet combined with segmented psychological intervention on the quality of life and hope level of colon cancer patients. Methods In a randomized controlled trial,100 patients with colon cancer admitted to our hospital from December 2019 to December 2022 were selected as the subjects of this study. According to the nursing methods,they were divided into control group(50 cases,given conventional psychological nursing intervention)and experimental group(50 cases,given internet combined segmented psychological intervention). The mental status,quality of life,hope level and nursing satisfaction of the patients in the two groups were compared. Results After nursing,the score of Brief Psychiatric Rating Scale was decreased in both groups,and the score of experimental group was better(P<0. 05). The scores of all dimensions of the concise Health Survey Questionnaire increased in both groups,and the scores of the experimental group were higher(P<0. 05). The scores of Herth Hope index were increased in both groups,and the scores of experimental group were higher(P<0. 05). The nursing satisfaction of experimental group(96. 00%)was higher than that of control group(80. 00%,P<0. 05). Conclusions The use of internet combined segmental psychological intervention in colon cancer patients can improve the mental state,improve the quality of life and hope level,with promotion value.
论著

MMP-2响应的多肽修饰的PAMAM纳米颗粒负载DOX在乳腺癌细胞中的效应

Effects of MMP-2 responding peptide-modified PAMAM nanoparticles loaded with DOX in breast cancer cells

:12-19
 
目的 构建尺寸可变纳米递送系统PAMAM/DOX-pep并进行表征,检测其理化性质并评价其体外抗肿瘤效果与靶向性。方法 将阿霉素(DOX)物理包埋在阳离子聚合物PAMAM的疏水空腔内,以4-(N-马来酰亚胺基甲基)环己烷羧酸N-羟基琥珀酰亚胺酯(SMCC)作为交联剂,采用金属基质蛋白酶(MMP-2)敏感的多肽pep(CPLGVRGC)串联小粒径纳米颗粒形成大尺寸纳米递送系统(PAMAM/DOX-pep),对各纳米颗粒的粒径、电位、理化性质以及对小鼠乳腺癌细胞(4T1)的抑制作用、细胞摄取效果和核靶向作用进行检测。结果 PAMAM/DOX粒径约为10 nm,载药率为23%,多肽pep交联后形成的PAMAM/DOX-pep粒径约为200 nm,可在低pH下缓释DOX,7天内体外保持稳定且溶血率低、安全无毒,其与MMP-2共孵育后细胞摄取量与核靶向性显著增加。结论 尺寸可变纳米颗粒有助于克服尺寸所引发的递送障碍,将药物靶向递送至乳腺癌细胞核内并发挥作用,为纳米递送系统的设计提供了新策略。
Objective To construct and characterize the size-variable nano-delivery system PAMAM/DOX-pep,examine its physicochemical properties and evaluate its antitumor and targeting effects in vitro. Methods Small particle size PAMAM/DOX was obtained by physically encapsulating DOX within the hydrophobic cavity of the cationic polymer PAMAM. The large size nano-delivery system(PAMAM/DOX-pep)was formed by tandem linking small size nanoparticles by MMP-2 sensitive peptide pep(CPLGVRGC)using SMCC as a cross-linker. The particle size,potential,physical and chemical properties,inhibitory effect,cell uptake and nuclear targeting effect of each nanoparticle on mouse breast cancer cells(4T1)were detected. Results The particle size of PAMAM/DOX was about 10 nm,and the drug loading rate was 23%. PAMAMAM/DOX-pep,formed after cross-linking of peptide,had a particle size of about 200 nm,which could release DOX slowly at low pH,and remained stable,safe and non-toxic in vitro for 7 days with low hemolysis rate,and its cellular uptake amount and nuclear targeting rate increased significantly after co-incubation with MMP. Conclusions Size-variable nanoparticles overcome size-induced delivery barriers to target and deliver drugs to the 4T1 nucleus,providing a new strategy for the design of nano delivery systems.
论著

医用几丁糖治疗不可复性关节盘前移位患者临床疗效及生活质量分析

The efficacy of medical chitosan and its effect on the quality of life of patients with anterior disc displacement without reduction

:59-64
 
目的 分析医用几丁糖治疗不可复性关节盘前移位患者的临床疗效及其对患者生活质量、恐惧疾病进展的影响。方法 将200例确诊为不可复性关节盘前移位患者分为2组,实验组以颞下颌关节微创灌洗术联合几丁糖治疗,对照组采用单一颞下颌关节微创灌洗术治疗,分别于治疗前和治疗后1、3、6、12个月采用一般资料调查表、口腔健康影响程度量表(OHIP)-14中文版、恐惧疾病进展简化量表(FoP-Q-SF)、视觉疼痛模拟量表等进行问卷调查并进行统计学分析。结果 治疗后,2组患者最大张口度、疼痛评分、生活质量及恐惧疾病进展水平较治疗前明显改善(P>0.05),且2组间比较,颞下颌关节微创灌洗术联合医用几丁糖在临床效果、生活质量及恐惧疾病进展水平长期效果明显优于单一颞下颌关节微创灌洗术(P>0.05)。结论 颞下颌关节微创灌洗术单一应用或联合医用几丁糖均对不可复性关节盘前移位患者疗效良好,对提升患者生活质量和缓解恐惧心理方面也有着重要意义,其中不可复性关节盘前移位联合应用几丁糖的长期疗效优于其单一应用。
Objective To analyze the efficacy of medical chitosan and its effect on the quality of life and fear of disease progression of patients with anterior disc displacement without reduction.Methods A total of 200 patients with anterior disc displacement without reduction were selected and divided into two groups,the experimental group was treated with temporomandibular joint lavage and medical chitosan,the control group was treated with temporomandibular joint lavage only.Before and after treatment with 1 month,3 months,6 months and 12 months,general data questionnaire,OHIP-14 Chinese version,FoP-Q-SF and visual analogue scale were used to investigate and the data were analyzed statistically.Results After treatment,the maximum mouth opening degree,pain score,quality of life and fear of disease progression were significantly improved compared with those before treatment,the differences were statistically significant(P>0.05).The long-term curative effect of the temporomandibular joint lavage and medical chitosan was better than that of the temporomandibular joint lavage only in clinical outcome,quality of life and fear of disease progression(P>0.05).Conclusions Temporomandibular joint lavage combined with medical chitosan and temporomandibular joint lavage only are effective in the treating anterior disc displacement without reduction,and can improve the quality of life and fear of disease progression,while the combined treatment has better long-term effect.
论著

乳果糖联合莫沙必利治疗功能性消化不良的疗效及对肠道菌群的影响

Efficacy of lactulose combined with mosapride in treating functional dyspepsia and its effect on intestinal flora

:42-45
 
目的 探讨功能性消化不良(FD)患者应用乳果糖联合莫沙必利治疗的临床疗效及药物对肠道菌群的影响。方法 选取2019年1月—2021年12月来院诊治的180例FD患者作为研究对象,随机分为2组,每组90例,对照组口服莫沙必利片,观察组服用莫沙必利片+乳果糖口服液,4周后观察2组患者治疗后临床症状改善率及肠道菌群数量的情况。结果 治疗4周后,观察组的总有效率(86.67%)高于对照组(72.22%),P<0.05;观察组的乳杆菌菌群数多于对照组,肠球菌、肠杆菌菌群数少于对照组,P<0.05。结论 乳果糖联合莫沙必利用于FD患者临床治疗,总有效率高于单用莫沙必利,患者症状获得有效改善,明显改善FD患者肠道菌群水平。
Objective To explore the clinical efficacy and effect on intestinal flora of lactulose combined with mosapride in patients with functional dyspepsia(FD).Methods A total of 180 FD patients admitted to the hospital in January 2019 and December 2021 were selected as the study subjects and randomly divided into two groups,90 cases in each group.The control group took oxapride orally and the observation group took lactulose oral solution additionally.After 4 weeks,the improvement rate of clinical symptoms and the number of intestinal flora of patients were observed.Results After 4 weeks of treatment,the total effective rate of the observation group(86.67%)was obviously higher than that of the control group(76.67%),P<0.05;the number of Lactobacillus in the observation group was higher than that of the control group,and the numbers of Enterococcus and Enterobacteria were less than that of the control group,P<0.05.Conclusions The total effective rate of lactulose combined with mosalabin for FD patients is higher than that of mossalapride alone.The symptoms are effectively improved,and the intestinal flora level of FD patients is significantly improved.
论著

MLR联合FT3对HBV相关慢加急性肝衰竭患者生存状况的预测效果

The predictive effect of MLR combined with FT3 on the survival of patients with chronic hepatitis B virus associated acute-on-chronic liver failure

:36-41
 
目的 分析单核细胞-淋巴细胞比率(MLR)联合游离三碘甲腺原氨酸(FT3)对乙型肝炎病毒(HBV)相关慢加急性肝衰竭(ACLF)患者生存状况的预测效果。方法 纳入我院在2019年1月—2022年1月期间收治的HBV-ACLF患者共187例进行研究,随访患者90 d的生存状况,其中69例死亡患者设为死亡组,其余118存活患者设为存活组。对2组患者的各项资料进行单因素分析,对差异有统计学意义的因素行Logistic多因素分析,分析HBV-ACLF患者死亡的危险因素,并分析MLR联合FT3对HBV-ACLF死亡的预测效果。结果 死亡组患者的年龄、肝硬化发生率、原发性腹膜炎发生率、肝肾综合征发生率、电解质紊乱发生率、终末期肝病模型、MLR、中性粒细胞与淋巴细胞计数比值、国际标准化比值、肌酐、白细胞计数、总胆红素水平均高于B组,血钠、FT3、总血清胆固醇水平均低于存活组,差异有统计学意义(P<0.05)。MLR≥0.60、FT3≤2.50 pmol/L均为HBV-ACLF患者死亡的危险因素(P<0.05)。MLR、FT3、MLR+FT3对HBV-ACLF患者死亡均有一定的预测价值,但MLR+FT3的预测价值高于其他单项预测。结论 MLR≥0.60、FT3≤2.50 pmol/L均为HBV-ACLF患者死亡的危险因素(P<0.05),且二者联合应用对HBV-ACLF患者死亡有较佳的预测价值。
Objective To analyze the predictive effect of mononuclear-lymphocyte ratio(MLR)combined with free triiodothyronine(FT3)on the survival of patients with hepatitis B virus-related acute-on-chronic liver failure(HBV-ACLF).Methods In the study,187 patients with HBV-ACLF from January 2019 to January 2022 in our hospital were included,and the survival status of the patients was followed up for 90 days.Among them,69 patients were included in the death group and the rest 118 patients were included in the survival group.The data of the two groups of patients were analyzed by univariate analysis,and the statistically significant factors were analyzed by Logistic multifactor analysis.The risk factors of death in patients with HBV-ACLF were analyzed,and the predictive effect of MLR combined with FT3 on the death of HBV-ACLF was analyzed.Results The age,incidence of cirrhosis,primary peritonitis,hepatorenal syndrome,electrolyte disturbance,ratio of neutrophil to lymphocyte count,international standardized ratio,model for end stage liver disease,MLR,creatinine,white blood cell count and total bilirubin of the patients in the death group were higher than those in survival group,and the levels of serum sodium,FT3 and total cholesterol were lower than those in survival group,the differences were significant(P<0.05).The results showed that MLR≥0.60,FT3≤2.50 pmol/L were risk factors for death of HBV-ACLF patients(P<0.05).MLR,FT3,MLR+FT3 had certain predictive value for the death of HBV-ACLF patients,but the predictive value of MLR+FT3 was higher than other single prediction.Conclusions MLR≥0.60 and FT3≤2.50 pmol/L are risk factors for death of patients with HBV-ACLF(P<0.05),and the combination of the two has a better predictive value for death of patients with HBV-ACLF.
论著

伊伐布雷定对冠心病合并心律失常患者心率变异性的影响及对心房颤动的防治效果

Effect of ivabradine on heart rate variability and prevention and treatment of atrial fibrillation in patients with arrhythmia in coronary heart disease

:83-88
 
目的 观察伊伐布雷定对冠状动脉粥样硬化性心脏病(CHD,以下简称:冠心病)合并心律失常患者心率变异性(HRV)的影响,及对心房颤动(AF)的防治效果。方法 本文为前瞻性研究,病例纳入时间为2021年1月—2023年1月,研究对象为焦作市第二人民医院收治的125例CHD合并心律失常患者,采用随机数字表法对入组患者进行分组,分别列为常规组(62例)和联合组(63例),常规组予常规药物治疗,联合组在常规药物治疗基础上联合伊伐布雷定治疗,比较2组患者治疗前后的HRV指标、血管内皮功能指标、心功能指标改善情况、心房颤动发生率及用药安全性。结果 治疗后,联合组24 h窦性心律RR间期标准差为(88.25±10.36)ms,24 h相邻正常RR间期差值均方根为(50.25±10.61)ms,24 h相邻正常RR间期差值>50 ms百分比为(12.04±3.41)%,均高于常规组[(81.44±10.77)ms、(43.28±10.71)ms、(10.77±3.08)%],组间比较差异具有统计学意义(P<0.05)。治疗后,联合组的血流介导下血管扩张程度为(12.33±3.27)%,硝酸甘油介导下血管内皮舒张程度为(9.83±2.21)%,均高于常规组[(10.25±3.23)%、(8.14±2.03)%]。AF发生率为4.76%(3/63),低于常规组16.13%(10/62),差异具有统计学意义(P<0.05)。治疗后,联合组的左室射血分数为(55.35±10.27)%,高于常规组(48.45±10.61)%,左室舒张末期内径为(40.24±10.37)mm,左室后壁厚度为(9.22±2.06)mm,均低于常规组[(46.33±10.28)mm、(10.88±2.46)mm],差异具有统计学意义(P<0.05)。治疗后,联合组的药物相关不良反应发生率为7.94%(5/63),略高于常规组6.45%(4/62),组间比较差异无统计学意义(P>0.05)。结论 伊伐布雷定联合常规药物治疗CHD合并心律失常能有效改善患者HRV指标、血管内皮功能及心功能,降低AF发生率,且未增加药物不良反应发生风险。
Objective To observe the effect of ivabradine on heart rate variability(HRV)in coronary heart disease(CHD)patients with arrhythmia and its preventive and therapeutic effects on atrial fibrillation(AF).Methods This is a prospective cohort study.The 125 CHD patients with arrhythmia were included from January 2021 to January 2023 and divided into the conventional group(62 cases)and the combined group(63 cases)by random number table.The conventional group was treated with conventional drugs,and the combined group was treated with ivabradine additionally.The HRV index,vascular endothelial function index,improvement of cardiac function indicators,incidence of AF and medication safety were compared.Results After treatment,the standard deviation of normal RR intervals in 24 h of the combination group was(88.25±10.36)ms,root mean square of successive RR interval differences in 24 h was(50.25±10.61)ms,and successive RR interval differences>50 ms was(12.04±3.41)%.Compared with the conventional group [(81.44±10.77)ms,(43.28±10.71)ms and(10.77±3.08)%],the above indicators were all higher(P<0.05).After treatment,the flow-mediated dilation and nitrite-mediated dilation of the combination group were(12.33±3.27)% and(9.83±2.21)%,respectively.Compared with the conventional group(10.25±3.23)% and(8.14±2.03)%),the above indicators were higher.The incidence of AF was 4.76%(3/63),which was lower(P<0.05)than the conventional group of 16.13%(10/62).After treatment,the left ventricular ejection fraction of the combination group was(55.35±10.27)%,which was higher than that of the conventional group(48.45±10.61)%.The left ventricular diastolic diameter was(40.24±10.37)mm and the left ventricular posterior wall thickness was(9.22±2.06)mm.Compared with the conventional group [(46.33±10.28)mm,(10.88±2.46)mm],the above indicators were all lower(P<0.05).After treatment,the incidence of drug-related side effects in the combination group was 7.94%(5/63),which was similar to 6.45%(4/62)in the conventional group(P>0.05).Conclusions The combination of ivabradine and conventional drugs in the treatment of CHD complicated with arrhythmia can effectively improve HRV indicators in patients,promote the recovery of vascular endothelial cell function and cardiac function,reduce the incidence of AF,and do not significantly increase the risk of drug side effects.
出版者信息








《广州医药》公众号